Table of Contents

1 Study Coverage

• 1.1 Heparin Sodium Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Heparin Sodium Market Size Growth Rate by Product
  • 1.4.2 Heparin Sodium
  • 1.4.3 Heparin Calcium
• 1.5 Market by End User
  • 1.5.1 Global Heparin Sodium Market Size Growth Rate by End User
  • 1.5.2 Treatment of Venous Thromboembolism
  • 1.5.3 Complications of Pregnancy
  • 1.5.4 Cardioversion of Atrial Fibrillation/Flutter
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Heparin Sodium Market Size
  • 2.1.1 Global Heparin Sodium Revenue 2014-2025
  • 2.1.2 Global Heparin Sodium Sales 2014-2025
• 2.2 Heparin Sodium Growth Rate by Regions
  • 2.2.1 Global Heparin Sodium Sales by Regions
  • 2.2.2 Global Heparin Sodium Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Heparin Sodium Sales by Manufacturers
  • 3.1.1 Heparin Sodium Sales by Manufacturers
  • 3.1.2 Heparin Sodium Sales Market Share by Manufacturers
  • 3.1.3 Global Heparin Sodium Market Concentration Ratio (CR5 and HHI)
• 3.2 Heparin Sodium Revenue by Manufacturers
  • 3.2.1 Heparin Sodium Revenue by Manufacturers (2014-2019)
  • 3.2.2 Heparin Sodium Revenue Share by Manufacturers (2014-2019)
• 3.3 Heparin Sodium Price by Manufacturers
• 3.4 Heparin Sodium Manufacturing Base Distribution, Product Types
  • 3.4.1 Heparin Sodium Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Heparin Sodium Product Type
  • 3.4.3 Date of International Manufacturers Enter into Heparin Sodium Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Heparin Sodium Sales by Product
• 4.2 Global Heparin Sodium Revenue by Product
• 4.3 Heparin Sodium Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Heparin Sodium Breakdown Data by End User

6 North America

• 6.1 North America Heparin Sodium by Countries
  • 6.1.1 North America Heparin Sodium Sales by Countries
  • 6.1.2 North America Heparin Sodium Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Heparin Sodium by Product
• 6.3 North America Heparin Sodium by End User

7 Europe

• 7.1 Europe Heparin Sodium by Countries
  • 7.1.1 Europe Heparin Sodium Sales by Countries
  • 7.1.2 Europe Heparin Sodium Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Heparin Sodium by Product
• 7.3 Europe Heparin Sodium by End User

8 Asia Pacific

• 8.1 Asia Pacific Heparin Sodium by Countries
  • 8.1.1 Asia Pacific Heparin Sodium Sales by Countries
  • 8.1.2 Asia Pacific Heparin Sodium Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Heparin Sodium by Product
• 8.3 Asia Pacific Heparin Sodium by End User

9 Central & South America

• 9.1 Central & South America Heparin Sodium by Countries
  • 9.1.1 Central & South America Heparin Sodium Sales by Countries
  • 9.1.2 Central & South America Heparin Sodium Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Heparin Sodium by Product
• 9.3 Central & South America Heparin Sodium by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Heparin Sodium by Countries
  • 10.1.1 Middle East and Africa Heparin Sodium Sales by Countries
  • 10.1.2 Middle East and Africa Heparin Sodium Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Heparin Sodium by Product
• 10.3 Middle East and Africa Heparin Sodium by End User

11 Company Profiles

• 11.1 Shenzhen Hepalink
  • 11.1.1 Shenzhen Hepalink Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Shenzhen Hepalink Heparin Sodium Products Offered
  • 11.1.5 Shenzhen Hepalink Recent Development
• 11.2 Nanjing King-friend
  • 11.2.1 Nanjing King-friend Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Nanjing King-friend Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Nanjing King-friend Heparin Sodium Products Offered
  • 11.2.5 Nanjing King-friend Recent Development
• 11.3 Dongcheng Biochemicals
  • 11.3.1 Dongcheng Biochemicals Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Dongcheng Biochemicals Heparin Sodium Products Offered
  • 11.3.5 Dongcheng Biochemicals Recent Development
• 11.4 Changzhou Qianhong Bio-pharma
  • 11.4.1 Changzhou Qianhong Bio-pharma Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Changzhou Qianhong Bio-pharma Heparin Sodium Products Offered
  • 11.4.5 Changzhou Qianhong Bio-pharma Recent Development
• 11.5 Changshan Biochemical
  • 11.5.1 Changshan Biochemical Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Changshan Biochemical Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Changshan Biochemical Heparin Sodium Products Offered
  • 11.5.5 Changshan Biochemical Recent Development
• 11.6 Dongying Tiandong Pharmaceutical
  • 11.6.1 Dongying Tiandong Pharmaceutical Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Dongying Tiandong Pharmaceutical Heparin Sodium Products Offered
  • 11.6.5 Dongying Tiandong Pharmaceutical Recent Development
• 11.7 Xinbai Pharmaceuticals
  • 11.7.1 Xinbai Pharmaceuticals Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Xinbai Pharmaceuticals Heparin Sodium Products Offered
  • 11.7.5 Xinbai Pharmaceuticals Recent Development
• 11.8 Bioibérica
  • 11.8.1 Bioibérica Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Bioibérica Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Bioibérica Heparin Sodium Products Offered
  • 11.8.5 Bioibérica Recent Development
• 11.9 Baxter
  • 11.9.1 Baxter Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Baxter Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Baxter Heparin Sodium Products Offered
  • 11.9.5 Baxter Recent Development
• 11.10 Opocrin
  • 11.10.1 Opocrin Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Opocrin Heparin Sodium Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Opocrin Heparin Sodium Products Offered
  • 11.10.5 Opocrin Recent Development
• 11.11 Aspen Oss
• 11.12 Pharma Action
• 11.13 Pfizer

12 Future Forecast

• 12.1 Heparin Sodium Market Forecast by Regions
  • 12.1.1 Global Heparin Sodium Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Heparin Sodium Revenue Forecast by Regions 2019-2025
• 12.2 Heparin Sodium Market Forecast by Product
  • 12.2.1 Global Heparin Sodium Sales Forecast by Product 2019-2025
  • 12.2.2 Global Heparin Sodium Revenue Forecast by Product 2019-2025
• 12.3 Heparin Sodium Market Forecast by End User
• 12.4 North America Heparin Sodium Forecast
• 12.5 Europe Heparin Sodium Forecast
• 12.6 Asia Pacific Heparin Sodium Forecast
• 12.7 Central & South America Heparin Sodium Forecast
• 12.8 Middle East and Africa Heparin Sodium Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Heparin Sodium Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
The global Heparin Sodium market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Heparin Sodium market based on company, product type, end user and key regions.

This report studies the global market size of Heparin Sodium in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Heparin Sodium in these regions.
This research report categorizes the global Heparin Sodium market by top players/brands, region, type and end user. This report also studies the global Heparin Sodium market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Shenzhen Hepalink
Nanjing King-friend
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Changshan Biochemical
Dongying Tiandong Pharmaceutical
Xinbai Pharmaceuticals
Bioibérica
Baxter
Opocrin
Aspen Oss
Pharma Action
Pfizer

Market size by Product
Heparin Sodium
Heparin Calcium
Market size by End User
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Heparin Sodium market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Heparin Sodium market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Heparin Sodium companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Heparin Sodium submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Heparin Sodium are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Heparin Sodium market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.